
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>L53</td><td>1</td><td>Cabotegravir</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Cabotegravir.</td></tr><tr><td>L53</td><td>1</td><td>Pantoprazole</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could
result in a higher serum level.</td></tr><tr><td>L53</td><td>1</td><td>Pantoprazole</td><td>Amlodipine</td><td>The metabolism of Pantoprazole can be decreased when combined with Amlodipine.</td></tr><tr><td>L53</td><td>1</td><td>Pantoprazole</td><td>Pregabalin</td><td>Pantoprazole may decrease the excretion rate of Pregabalin which could result in
a higher serum level.</td></tr><tr><td>L53</td><td>1</td><td>Pregabalin</td><td>Acetylsalicylic acid</td><td>The risk or severity of angioedema can be increased when Pregabalin is combined
with Acetylsalicylic acid.</td></tr><tr><td>L53</td><td>1</td><td>Pregabalin</td><td>Amlodipine</td><td>Pregabalin may increase the bradycardic activities of Amlodipine.</td></tr><tr><td>L53</td><td>1</td><td>Pregabalin</td><td>Brotizolam</td><td>The therapeutic efficacy of Brotizolam can be increased when used in combination
with Pregabalin.</td></tr><tr><td>L53</td><td>1</td><td>Rilpivirine</td><td>Acetylsalicylic acid</td><td>The metabolism of Acetylsalicylic acid can be decreased when combined with
Rilpivirine.</td></tr><tr><td>L53</td><td>1</td><td>Rilpivirine</td><td>Amlodipine</td><td>The metabolism of Rilpivirine can be decreased when combined with Amlodipine.</td></tr><tr><td>L53</td><td>1</td><td>Rilpivirine</td><td>Pantoprazole</td><td>The therapeutic efficacy of Rilpivirine can be decreased when used in
combination with Pantoprazole.</td></tr><tr><td>L53</td><td>1</td><td>Rilpivirine</td><td>Pregabalin</td><td>The risk or severity of QTc prolongation can be increased when Pregabalin is
combined with Rilpivirine.</td></tr><tr><td>L53</td><td>1</td><td>Rosuvastatin</td><td>Pantoprazole</td><td>The excretion of Rosuvastatin can be decreased when combined with Pantoprazole.</td></tr><tr><td>L53</td><td>1</td><td>Rosuvastatin</td><td>Rilpivirine</td><td>Rilpivirine may decrease the excretion rate of Rosuvastatin which could result
in a higher serum level.</td></tr></tbody></table></div>
